Category Archives: Pancreatic Cancer Medical Treatment
Results in on Double Punch Vaccine: Why the FDA Granted Orphan Status to CRS-207 + GVAX in Pancreatic Cancer this Past Fall
A quick note related to an earlier Pancreatica blog posting from October 24, 2013. At the 2014 Gastrointestinal Cancers Symposium in San Francisco (January 16-18) as hosted by the American Society of Clinical Oncology (ASCO), the results of an interesting vaccine study for pancreatic cancer were released. By way of background in the fall 2013, […]
Penetrating the Stroma: Plerixafor Inhibits Chemokine Ligand 12 (of CXCR4) Allowing for Enhanced Biological Therapy in Adenocarcinoma of the Pancreas
The physical size of the structural aspect of pancreatic adenocarcinoma can be misleading as perhaps 90% of the tumor bulk is actually the somewhat inert – and not completely understood – stromal tissue that the “surrounds” the malignant aspect of pancreatic cancer. One practical effect of the stromal tissue is that it may physically, through […]
Do Women Respond More Favorably Than Men to the FOLFIRINOX Regimen in Advanced Cancer of the Pancreas ?
We have come across an interesting recent finding from researchers in Austria. Greil and colleagues from the Paracelsus Medical University in Salzburg, have published the results of their work which will officially come out in the January issue of the International Journal of Oncology. These findings appear to suggest that the female gender may be […]